Clinical Trial: A Study to Assess the Safety of ARGX-109 in Healthy Volunteers

U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT06799416) titled 'A Study to Assess the Safety of ARGX-109 in Healthy Volunteers' on Jan. 23.

Brief Summary: This study aims to assess the safety of ARGX-109 in healthy adults. Another aim is to measure the amount of ARGX-109 in the blood over time to learn how it moves through the body and acts in the body. Each participant will remain in the study for approximately 20 weeks.

Study Start Date: Jan. 14

Study Type: INTERVENTIONAL

Condition: Healthy Volunteer

Intervention: BIOLOGICAL: ARGX-109

administrations of ARGX-109

OTHER: Placebo

administrations of placebo comparator

Recruitment Status: RECRUITING

Sponsor: argenx

Disclaimer: Curated b...